Fontinalis Partners Leads Growth Financing for Nano-C

Nano-C, Inc., a leading developer of nanostructured carbon for use in energy and electronics applications, today announces a growth financing, which was led by Fontinalis Partners and saw continued participation from existing investors. Terms of the transaction are not disclosed.

Nano-C, Inc., founded in 2001, is a leader in nanostructured carbon, a critical element in emerging high-value applications in the electronics and energy markets. Nano-C is poised to enter a growth stage through its unique and well-positioned IP in specific applications. This growth stage comes at an opportune time as the company stands to benefit from favorable trends, such as demand for lighter weight, more efficient, and inherently more versatile components--all at a lower total cost to the consumer.

Nano-C manufactures carbon fullerenes, single-walled carbon nanotubes (SWCNT) and their chemical derivatives. These new forms of carbon are a radical departure from the commonly known forms of carbon: diamond, graphite, activated carbon, and carbon black. Their unique properties are essential for key technologies of the future, including transparent conducting films for displays, photo-resists, flash memory, transistors, photo-detectors, sensors, solar panels, batteries, ultra-capacitors, fuel cells, and composite materials, among others.

"Nano-C is pleased to complete this financing and believes the addition of Fontinalis Partners to be an affirmation of the company's market leading position in key markets, as well as optimism about future applications," says Viktor Vejins , President and CEO of Nano-C. "This financing provides Nano-C with the opportunity to advance its applications in high-value markets."

Fontinalis Partners, with offices in Detroit and Boston, is a strategic investment firm that was founded in 2009 to invest in innovative companies that are developing and commercializing technologies that support next-generation mobility. Nano-C's technology has numerous long-term applications in transportation and mobility, including vehicle structure (composite materials); intelligence (more efficient and lighter-weight sensors and electronic components for vehicle-to-vehicle communication); power train (more efficient energy generation and storage for fuel cells, batteries, and capacitors); and other advanced vehicle-specific applications.

"The core tenets of Nano-C's technology--including the enabling of cheaper, smaller, lighter, and more reliable components--align well with current and future technology demands," says Chris Cheever , a Founder and Managing Director of Fontinalis Partners who joins Nano-C's Board of Directors. "We look forward to supporting the company's current applications as well as a variety of exciting, next-generation solutions for transportation and mobility."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nano-C. (2019, February 11). Fontinalis Partners Leads Growth Financing for Nano-C. AZoNano. Retrieved on October 06, 2024 from https://www.azonano.com/news.aspx?newsID=26960.

  • MLA

    Nano-C. "Fontinalis Partners Leads Growth Financing for Nano-C". AZoNano. 06 October 2024. <https://www.azonano.com/news.aspx?newsID=26960>.

  • Chicago

    Nano-C. "Fontinalis Partners Leads Growth Financing for Nano-C". AZoNano. https://www.azonano.com/news.aspx?newsID=26960. (accessed October 06, 2024).

  • Harvard

    Nano-C. 2019. Fontinalis Partners Leads Growth Financing for Nano-C. AZoNano, viewed 06 October 2024, https://www.azonano.com/news.aspx?newsID=26960.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.